ArticleMaterials (Basel, Switzerland)2025
Dual-Activated Tamarix Gallica-Derived Carbons for Enhanced Glyphosate Adsorption: A Comparative Study of Phosphoric and Sulfuric Acid Activation.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Kinetic and isothermal insights on phenol removal via biochar from vicia Faba stems.Scientific reports · 2025Article
- Mesoporous activated carbon from Tabebuia aurea leaves for effective adsorptive removal of 2,4-dichlorophenoxyacetic acid.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the efficacy of activated carbons (ACs) derived from Tamarix gallica (TG) leaves for glyphosate removal from aqueous solutions. Two chemical activation methods, using phosphoric acid (H
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.